20 Fastest Growing Health Tech Companies in the World
Yahoo FinanceApr 25 11:34 ET
Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live
GlobeNewswireApr 17 07:00 ET
Banzai Welcomes Over 580 New Customers In Q1, A Quarterly Increase Of 46%
Banzai International, Inc. (NASDAQ:BNZI), a leading marketing technology company providing essential marketing and sales solutions, announced exceptional customer growth in Q1 2024. Banzai added over
BenzingaApr 16 08:04 ET
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Seeking AlphaApr 14 17:56 ET
Needham Reiterates Buy on Enovis, Maintains $82 Price Target
Needham analyst Mike Matson reiterates Enovis (NYSE:ENOV) with a Buy and maintains $82 price target.
BenzingaApr 10 08:18 ET
Not Many Are Piling Into Enovis Corporation (NYSE:ENOV) Just Yet
You may think that with a price-to-sales (or "P/S") ratio of 2x Enovis Corporation (NYSE:ENOV) is a stock worth checking out, seeing as almost half of all the Medical Equipment companies in the United
Simply Wall StApr 1 09:49 ET
Only 4.8% increase in 2024? Needham is cautious about the recovery of the orthopedic device market
A recent analysis by Needham, a well-known Wall Street investment agency, shows that the backlog of surgeries associated with the pandemic will drive sales of orthopedic medical devices this year.
Zhitong FinanceApr 1 02:40 ET
Don't Expect Pandemic Backlog to Fuel Orthopedic Sales, Says Needham
Seeking AlphaMar 31 19:46 ET
NXST, GNTX, and COKE Among the Best Mid-cap Technical Ideas - Roth MKM
Seeking AlphaMar 28 12:39 ET
Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE:ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced
GlobeNewswireMar 28 07:00 ET
Here's Why Enovis (NYSE:ENOV) Can Afford Some Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much
Simply Wall StFeb 26 08:38 ET
Needham Sees Orthopedics Market Slowing; Favors Enovis, Paragon 28
Seeking AlphaFeb 25 18:50 ET
Enovis Is Maintained at Overweight by Wells Fargo
Enovis Is Maintained at Overweight by Wells Fargo
Dow JonesFeb 23 13:10 ET
Enovis Corporation (NYSE:ENOV) Q4 2023 Earnings Call Transcript
Yahoo FinanceFeb 23 10:20 ET
Enovis Price Target Raised to $75.00/Share From $73.00 by Canaccord Genuity
Enovis Price Target Raised to $75.00/Share From $73.00 by Canaccord Genuity
Dow JonesFeb 23 09:49 ET
Enovis Is Maintained at Buy by Needham
Enovis Is Maintained at Buy by Needham
Dow JonesFeb 23 05:09 ET
Express News | Needham Maintains Buy on Enovis, Raises Price Target to $82
Moomoo 24/7Feb 23 05:00 ET
Enovis Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 02/23/2024 28.53% Needham $73 → $82 Maintains Buy 02/13/2024 12.85% Stephens & Co. → $72 Initiates Coverag
BenzingaFeb 23 04:58 ET
Enovis Up Over 7%, on Track for Largest Percent Increase Since February 2021 -- Data Talk
Enovis Corporation ( ENOV ) is currently at $64.55, up $4.28 or 7.1% --Would be highest close since July 26, 2023, when it closed at $64.99 --On pace for largest percent increase since Feb. 19, 2021
Dow JonesFeb 22 14:14 ET
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
Enovis Corporation's (NYSE:ENOV) fourth-quarter net sales reached $455 million, up 11% Y/Y, including 8% organic growth, beating the consensus of $445.36 million.Fourth quarter results reflect continu
BenzingaFeb 22 13:50 ET
No Data
No Data